The level of expression of CD25 (MFI) on the membrane of various subpopulations of regulatory T-lymphocytes (in relative units) in the blood of patients with Graves' disease in dynamics after radionuclide treatment (RIT), Me (Q1–Q3). This evidence concerns the gene IL2RA and Graves disease.